The addition of avibactam renders piperacillin an effective treatment for Mycobacterium abscessus infection in an in vivo model
Abstract Treating M. abscessus infection is challenging due to the potent β-lactamase BlaMab (Beta-lactamase of M. abscessus ). Avibactam is a non-β-lactam, β-lactamase inhibitor shown to inhibit BlaMab. We tested whether avibactem can render piperacillin effective against M. Abscessus. In-vitro, av...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13756-018-0448-4 |